{
  "id": "f734e5da58c4b48e",
  "title": "Outlook Therapeutics Submits Type A Meeting Request to FDA Following Complete Response Letter",
  "description": "20260211T143000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/02/11/tmt-newswire/globenewswire/outlook-therapeutics-submits-type-a-meeting-request-to-fda-following-complete-response-letter/2276282",
  "published_at": "20260211T143000Z",
  "fetched_at": "2026-02-12T00:28:38.246764+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/02/11/tmt-newswire/globenewswire/outlook-therapeutics-submits-type-a-meeting-request-to-fda-following-complete-response-letter/2276282",
    "url_mobile": "https://www.manilatimes.net/2026/02/11/tmt-newswire/globenewswire/outlook-therapeutics-submits-type-a-meeting-request-to-fda-following-complete-response-letter/2276282/amp",
    "title": "Outlook Therapeutics Submits Type A Meeting Request to FDA Following Complete Response Letter",
    "seendate": "20260211T143000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/02/11/934119.png",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}